| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 19,510,383 | 23,241,199 | ||
| Marketable securities | 79,055,588 | 99,559,482 | ||
| Receivables | 59,167 | 59,509 | ||
| Prepaid expenses and other current assets | 2,326,543 | 1,266,356 | ||
| Total current assets | 100,951,681 | 124,126,546 | ||
| Property and equipment, net | 11,068,078 | 7,995,259 | ||
| Lease right-of-use assets, net | 13,929,710 | 939,204 | ||
| Other assets | 488,738 | 508,002 | ||
| Total assets | 126,438,207 | 133,569,011 | ||
| Accounts payable | 2,719,416 | 4,812,356 | ||
| Accrued expenses | 9,932,488 | 7,359,232 | ||
| Lease liabilities, current | 120,094 | 849,505 | ||
| Cirm liability, current | 3,376,259 | 3,376,259 | ||
| Deferred revenue, current | 12,000,000 | 12,000,000 | ||
| Total current liabilities | 28,148,257 | 28,397,352 | ||
| Cirm liability, net of current | 0 | 0 | ||
| Lease liabilities, net of current | 14,422,695 | 194,603 | ||
| Total long-term liabilities | 14,422,695 | 194,603 | ||
| Total liabilities | 42,570,952 | 28,591,955 | ||
| Common stock, 0.001 par value, 100,000,000 shares authorized, 45,716,975 and 45,582,288 shares issued and outstanding, respectively | 45,717 | 45,712 | ||
| Additional paid-in capital | 357,684,987 | 353,680,694 | ||
| Accumulated other comprehensive income | 844,122 | 1,387,574 | ||
| Accumulated deficit | -274,707,571 | -250,136,924 | ||
| Total stockholders' equity | 83,867,255 | 104,977,056 | ||
| Total liabilities and stockholders' equity | 126,438,207 | 133,569,011 | ||
CAPRICOR THERAPEUTICS, INC. (CAPR)
CAPRICOR THERAPEUTICS, INC. (CAPR)